Acquisition Aligned Recent acquisitions indicate a shift in ownership and strategic expansion. Tailor outreach to Final Bell Corp and Closing Bell stakeholders to position integrated dose-controlled hardware, fast-acting gummies, and a scalable distribution platform as value-added solutions for their portfolio.

East Coast Expansion Dosist expanded to Garden City, New York, signaling a readiness to scale beyond its West Coast base. Target national retailers, pharma-grade distributors, and on-site wellness programs in East Coast markets seeking premium cannabinoid-based solutions with precise dosing.

Tech Enabled The company relies on a modern tech stack for analytics, CRM, and operations. Propose partner integrations or co-marketing technology collaborations (CRM, analytics dashboards, customer support) to streamline channel programs, loyalty, and patient/customer education workflows.

Awarded Credibility Recognized by Time Magazine, Fast Company, and LinkedIn as a top startup and innovator, Dosist has strong branding credibility. Leverage this in executive outreach to premier wellness retailers, hospitality venues, and healthcare-adjacent partners seeking trusted, science-backed wellness solutions.

Product Portfolio Growth Historical moves from THC-focused to no-THC CBD products and the Studio branding initiative suggest appetite for product line diversification. Propose joint development or co-branded lines, and discuss private-label or contract manufacturing opportunities to accelerate market entry for partners.